BRONTE, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 3.365
EU - Europa 1.419
AS - Asia 1.264
SA - Sud America 181
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 6.270
Nazione #
US - Stati Uniti d'America 3.329
SG - Singapore 539
RU - Federazione Russa 401
CN - Cina 284
IT - Italia 280
FI - Finlandia 176
BR - Brasile 148
HK - Hong Kong 134
DE - Germania 119
VN - Vietnam 102
UA - Ucraina 88
PL - Polonia 72
GB - Regno Unito 67
FR - Francia 62
IE - Irlanda 55
IN - India 41
JP - Giappone 33
TR - Turchia 25
BD - Bangladesh 23
SE - Svezia 23
CA - Canada 21
KR - Corea 21
RO - Romania 16
BE - Belgio 12
CI - Costa d'Avorio 11
AT - Austria 10
NL - Olanda 10
PK - Pakistan 9
AR - Argentina 8
ES - Italia 8
EC - Ecuador 7
ID - Indonesia 7
LT - Lituania 6
MX - Messico 6
PH - Filippine 6
ZA - Sudafrica 6
NP - Nepal 5
SA - Arabia Saudita 5
CL - Cile 4
CZ - Repubblica Ceca 4
IQ - Iraq 4
KE - Kenya 4
MY - Malesia 4
AZ - Azerbaigian 3
CO - Colombia 3
DZ - Algeria 3
EG - Egitto 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
CH - Svizzera 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
NI - Nicaragua 2
PE - Perù 2
PY - Paraguay 2
SN - Senegal 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
GH - Ghana 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
MD - Moldavia 1
ML - Mali 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 6.270
Città #
Fairfield 454
Ashburn 444
Singapore 383
Woodbridge 232
Chandler 218
Houston 203
Seattle 182
Wilmington 176
Cambridge 155
Ann Arbor 151
Hong Kong 129
San Jose 111
Palermo 73
Moscow 63
Zgierz 60
Beijing 56
Dublin 55
New York 50
Medford 49
Council Bluffs 48
Jacksonville 48
Altamura 45
Los Angeles 44
Des Moines 42
Ho Chi Minh City 37
Hanoi 34
Princeton 32
Tokyo 32
Lawrence 31
Nanjing 31
Frankfurt am Main 28
San Diego 27
The Dalles 27
Lauterbourg 26
Dallas 22
Helsinki 22
Boardman 17
Dearborn 17
Santa Clara 16
Tulsa 16
London 14
São Paulo 14
Buffalo 13
Brussels 12
Orem 12
Abidjan 11
Chennai 11
Izmir 11
Phoenix 11
Jiaxing 10
Nanchang 10
Shenyang 10
Chicago 9
Washington 9
Changsha 8
Hebei 8
Hefei 8
Kumar 8
Ludwigshafen am Rhein 8
Milan 8
Paris 8
Rome 8
Ottawa 7
San Paolo di Civitate 7
Stockholm 7
Amsterdam 6
Atlanta 6
Belo Horizonte 6
Guangzhou 6
Jinan 6
Munich 6
Napoli 6
Saint Petersburg 6
Warsaw 6
Zhengzhou 6
Haiphong 5
Istanbul 5
Johannesburg 5
Nuremberg 5
Poplar 5
Rio de Janeiro 5
Bologna 4
Boston 4
Cagliari 4
Denver 4
Düsseldorf 4
Manchester 4
Montreal 4
Nairobi 4
Norwalk 4
Nürnberg 4
Seoul 4
Shenzhen 4
Tampa 4
Ancona 3
Auburn Hills 3
Bremen 3
Charlotte 3
Delhi 3
Dhaka 3
Totale 4.288
Nome #
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals 324
Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis 271
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis 258
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 257
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 253
Targeted Therapies in Hepatocellular Carcinoma 252
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors 252
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. 246
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C 235
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. 227
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. 226
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 225
STAGING OF FIBROSIS BY LIVER STIFFNESS MEASUREMENT IN THALASSEMICS WITH IRON OVERLOAD 215
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. 214
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C 212
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy 195
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 195
HCV clearance among hemophiliacs and beta-thalassemics 194
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. 191
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience 191
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. 189
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication? 185
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) 183
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis 176
Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis 172
Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis 171
Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. 156
GENETIC, VIROLOGICAL AND CLINICAL FACTORS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA DEVELOPEMENT IN PATIENTS WITH CHRONIC HBV AND HCV INFECTION 146
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC 120
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene 119
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease 105
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy 88
Totale 6.443
Categoria #
all - tutte 21.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202186 0 0 0 0 0 0 0 0 0 0 31 55
2021/2022411 12 75 26 12 19 20 35 29 36 50 31 66
2022/2023558 51 138 6 69 58 84 33 29 49 2 24 15
2023/2024230 10 29 25 27 18 50 21 15 0 6 3 26
2024/2025549 13 25 19 49 30 15 51 32 38 54 92 131
2025/20262.205 148 63 114 201 252 371 338 216 165 240 97 0
Totale 6.443